Research investigating clastogenic factors and ROS in SSc requires a modern mechanistic bridge to better understand their roles and define the relationship between the clastogenic factor (e.g., inosine triphosphate/diphosphate or other) and elevated NADPH oxidase activity. This evidence concerns the gene FMO5 and systemic sclerosis.